Search

everythinglearnresearchcommunity

for

Search:↓

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Telogen effluvium is a condition that causes temporary hair loss.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

For hair fungal infections, take oral antifungals; for skin and nail infections, use topical antifungals, and keep affected areas cool and dry.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

Tea leaf extract tonic promotes hair growth better than controls but has stability issues.

TCM-derived nanovesicles show promise for wound healing and skin regeneration but need more research.

Tofacitinib may help treat hair loss in children with alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.